2022
DOI: 10.1016/j.indcrop.2022.115270
|View full text |Cite
|
Sign up to set email alerts
|

Research progress on the biosynthesis and metabolic engineering of the anti-cancer drug camptothecin in Camptotheca acuminate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(11 citation statements)
references
References 112 publications
0
8
0
Order By: Relevance
“…The small oxo groups in 11 and 24 likely minimize negative impacts on target binding despite some steric effects, which is supported by 10,11-ethylenedioxy analogues being less effective than 10,11-methylenedioxy counterparts. 49 The more cytotoxic 11 versus the essentially similar 10,11-dimethoxycamptothecin (DMO-CPT, 25, Figure 1) verifies this speculation as well. In 25, the methoxy groups create large steric clashes with DNA base pairs, preventing intercalation and stable complex formation.…”
Section: Semisynthesis and Total Synthesis Of Camptothecin Derivative...mentioning
confidence: 64%
See 2 more Smart Citations
“…The small oxo groups in 11 and 24 likely minimize negative impacts on target binding despite some steric effects, which is supported by 10,11-ethylenedioxy analogues being less effective than 10,11-methylenedioxy counterparts. 49 The more cytotoxic 11 versus the essentially similar 10,11-dimethoxycamptothecin (DMO-CPT, 25, Figure 1) verifies this speculation as well. In 25, the methoxy groups create large steric clashes with DNA base pairs, preventing intercalation and stable complex formation.…”
Section: Semisynthesis and Total Synthesis Of Camptothecin Derivative...mentioning
confidence: 64%
“…Ring systems may also restrict conformational flexibility, hampering adaptation to the protein active site. The small oxo groups in 11 and 24 likely minimize negative impacts on target binding despite some steric effects, which is supported by 10,11-ethylenedioxy analogues being less effective than 10,11-methylenedioxy counterparts . The more cytotoxic 11 versus the essentially similar 10,11-dimethoxycamptothecin (DMO-CPT, 25 , Figure ) verifies this speculation as well.…”
Section: Progress In Structural Modification Of Camptothecinsmentioning
confidence: 82%
See 1 more Smart Citation
“…This pentacycle quinoline alkaloid can selectively inhibit the deoxyribonucleic acid (DNA) topoisomerase I as well as induct the break of double-stranded DNA (dsDNA) in cancer cells. 106 Notwithstanding, its broader therapeutic application is hindered by several poor clinical outcomes ascribed to this drug such as low bioavailability and systemic toxicity. In this regard, various modifications of CPT have been reported in the last years.…”
Section: Anticancer Drugsmentioning
confidence: 99%
“…Betulinic acid (isolated from Betula alba) (Fulda, 2008) 26 , Camptothecin and its analogues i.e. Irinotecan and Topotecan (isolater form Camptotheca acuminata) are known to inhibit topoisomerase [27][28] Fig. 2, Table 1.…”
Section: Fig 2: Mode Of Action Of Anti-cancer Compoundsmentioning
confidence: 99%